[HTML][HTML] Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial
…, F Brockhaus, J Zhang, G Angyalosi, E He… - Journal of Cystic …, 2011 - Elsevier
BACKGROUND: A light-porous-particle, dry-powder formulation of tobramycin was developed,
using PulmoSphere® technology, to improve airway delivery efficiency, substantially …
using PulmoSphere® technology, to improve airway delivery efficiency, substantially …
A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with …
W Wen, S Sitar, SY Lynch, E He… - Expert opinion on …, 2015 - Taylor & Francis
Full article: A multicenter, randomized, double-blind, placebo-controlled trial to assess the
efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with …
efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with …
[PDF][PDF] The undiagnosed pandemic: burnout and depression within the surgical community
…, DA Jardine, AJ Stefanou, B Aziz, E He… - Current problems in …, 2017 - Elsevier
Medical School training is among the most challenging, stressful, and emotionally taxing
experiences during the development process for physicians [48]. It is well known that medical …
experiences during the development process for physicians [48]. It is well known that medical …
Meteorin-β/Meteorin like/IL-41 attenuates airway inflammation in house dust mite-induced allergic asthma
…, TF Leung, GWK Wong, WH Ko, M Cai, EJ He… - Cellular & Molecular …, 2022 - nature.com
We sought to examine the regulatory effect of Meteorin-β (Metrnβ)/Meteorin like (Metrnl)/IL-41
on lung inflammation in allergic asthma. We found that Metrnβ was elevated significantly in …
on lung inflammation in allergic asthma. We found that Metrnβ was elevated significantly in …
Tobramycin inhalation powder in cystic fibrosis patients: response by age group
DE Geller, SZ Nasr, S Piggott, E He, G Angyalosi… - Respiratory …, 2014 - rc.rcjournal.com
BACKGROUND: Tobramycin powder for inhalation (TIP) is a drug-device combination designed
to reduce treatment time and improve ease of use compared with tobramycin inhalation …
to reduce treatment time and improve ease of use compared with tobramycin inhalation …
[HTML][HTML] Effect of a multi-layer, extended-release methylphenidate formulation (PRC-063) on sleep in adults with ADHD: a randomized, double-blind, forced-dose …
Background The effects of stimulant treatment on sleep in adults with attention-deficit/hyperactivity
disorder (ADHD) are complex and varied, with some individuals experiencing …
disorder (ADHD) are complex and varied, with some individuals experiencing …
[HTML][HTML] The nociceptin/orphanin FQ receptor partial agonist sunobinop promotes non-REM sleep in rodents and patients with insomnia
…, DJ Kyle, RP Kapil, A Cipriano, E He… - The Journal of …, 2024 - Am Soc Clin Investig
The potent and partial agonist sunobinop activates the nociceptin/orphanin-FQ peptide
receptor and promotes non-REM sleep in rodents and patients with insomnia.
receptor and promotes non-REM sleep in rodents and patients with insomnia.
12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.
W Wen, L Taber, SY Lynch, E He… - Journal of Opioid …, 2015 - europepmc.org
Objective To characterize the long-term safety and effectiveness of Hysingla™ ER, single-entity,
once-daily, extended-release hydrocodone bitartrate tablets formulated with abuse-…
once-daily, extended-release hydrocodone bitartrate tablets formulated with abuse-…
Effect of a multilayer, extended-release methylphenidate formulation (PRC-063) on sleep in adolescents with attention-deficit/hyperactivity disorder: a randomized …
…, C Surman, A Khullar, J Owens, E He… - Journal of Child and …, 2021 - liebertpub.com
Objectives: We analyzed patient-reported sleep parameters for an extended-release
methylphenidate formulation (PRC-063) in adolescents with attention-deficit/hyperactivity disorder. …
methylphenidate formulation (PRC-063) in adolescents with attention-deficit/hyperactivity disorder. …
Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic …
A Bartoli, E Michna, E He, W Wen - Postgraduate Medicine, 2015 - Taylor & Francis
Background: Hydrocodone/acetaminophen combination analgesics are frequently prescribed
for chronic pain management; however, acetaminophen presents potential hepatotoxicity …
for chronic pain management; however, acetaminophen presents potential hepatotoxicity …